NSN 6505-01-518-8234, 6505015188234
SODIUM HYALURONATE INJECTION

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 015188234
Codification Country: United States
Item Name Code: INC 35854
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-518-8234

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-518-8234

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-518-8234

National Stock Number (NSN) 6505-01-518-8234, or NIIN 015188234, (sodium hyaluronate injection) was assigned March 24, 2004 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There are 4 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 3 suppliers. Today, 3 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Jun 19, 2018. There have been 3 contracts issued for this part number, with 3 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DP18P0525, SPE2DP18P0507, SPE2DP17P0183, SPE2DP17P0183, SPE2DP17P0183. The total value of the awarded contracts has been US$ 9,108.00.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 35854. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505015188234 does not contain precious metals.

This information was last updated on Aug 01, 2025.

Technical Characteristics

PRIMARY CONTAINER TYPE: (CQCT) SYRINGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 14.000 KILOGRAMS PER CUBIC DECIMETER SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: (CSGS) INTRAOCULAR
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 0.850 MILLILITERS
SPECIAL FEATURES: (FEAT) IN DISPOSABLE GLASS SYRINGE WITH STERILE SINGLE USE 27 GAGE CANNULA; REFRIGERATED HEALON GV SHOULD BE HELD AT ROOM TEMP FOR APPROX 30 MINUTES BEFORE USE; PROTECT FROM FREEZING AND EXPOSURE TO LIGHT; FOR USE IN ANTERIOR SEGMENT OPHTHALMIC SURGICAL PROCEDURES
TOTAL PRIMARY CONTAINER QUANTITY: (CSCW) 1
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 14.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) HEALON GV 14MG PER ML 0.85 ML GLASS SYRINGE WITH 27 GAGE CANNULA